Sculptor Capital LP Anavex Life Sciences Corp. Transaction History
Sculptor Capital LP
- $2.76 Billion
- Q3 2024
A detailed history of Sculptor Capital LP transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Sculptor Capital LP holds 370,400 shares of AVXL stock, worth $4.09 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
370,400
Previous 370,400
-0.0%
Holding current value
$4.09 Million
Previous $1.56 Million
34.55%
% of portfolio
0.08%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
155Shares Held
27.3MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$70.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$52.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$33.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$20.8 Million0.0% of portfolio
-
Wealthgarden F.S. LLC El Segundo, CA910KShares$10.1 Million0.32% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $860M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...